<DOC>
	<DOCNO>NCT02355769</DOCNO>
	<brief_summary>Preventing heart failure ( HF ) deterioration great challenge contemporary medicine . The progress course HF increase frequency subsequent hospitalization ( approximately 30 % hospitalization repeat one ) . It estimate cost hospital stay constitute nearly 2/3 healthcare cost provide HF patient . The difficulty treatment patient HF deterioration associate numerous comorbidities coexist complication ( i.e . aggravation ischaemic heart disease , lung disease , infection , electrolyte disturbance , anaemia , renal failure well operation , particular emergency one ) . Our study aim evaluation complex pathophysiological background relate heart failure deterioration respect effect apply in-hospital treatment .</brief_summary>
	<brief_title>Complex Pathophysiological Background Heart Failure Deterioration</brief_title>
	<detailed_description>PURPOSE : Treatment patient heart failure ( HF ) great challenge contemporary medicine . HF frequency European population assess 0.4 - 2 % . This disease characterize high morbidity mortality rate , poor quality life necessity frequent hospitalization . Along medicine progress , particular scope acute coronary syndrome treatment , number HF patient constantly grow . The essential problem connect HF progress course increase frequency subsequent hospitalization ( approximately 30 % hospitalization repeat one ) . It estimate cost hospital stay constitute nearly 2/3 healthcare cost provide HF patient . In United States approximately 50 % HF patient rehospitalized within 6 month discharge 70 % hospitalization cause HF deterioration.The prognosis HF closely connect progression disease define accordance NYHA ( New York Heart Association ) functional classification . The yearly mortality rate among NYHA class : class 1 - 10 % , class 2 - 10-20 % , class 3 - 20-40 % , class 4 - mortality 40-60 % . Over half patient symptomatic HF die within 4 year observation The high in-hospital mortality great problem result natural history HF progression , also number coexist complication ( i.e . aggravation ischaemic heart disease , lung disease , infection , electrolyte disturbance , anaemia , renal failure well operation , particular emergency one ) . The optimal scheme identify individual risk fundamental importance guide safe therapy . Undoubtedly hemodynamic status change hospitalization one main predictive factor treatment response occurrence adverse effect therapy , i.e . renal function worsening . However , clear guideline perform safe effective non-invasive hemodynamic monitoring . AIMS : The evaluation complex pathophysiological feature relate heart failure deterioration , include parameter characterize i.e . cardiovascular hemodynamics , hydration status , renal failure , iron metabolism gas exchange , respect effect apply in-hospital treatment The evaluation clinical value parameter characterize i.e . cardiovascular hemodynamics , hydration status , renal failure , iron metabolism gas exchange prognosis patient heart failure deterioration METHODS : All recruit patient undergo following assessment : Clinical examination Laboratory test , ncluding i.e . white blood cell count , red blood cell count , hemoglobin , hematocrit , mean cell volume ( MCV ) , red cell distribution width ( RDW ) ; sodium , potassium , creatinine , estimate glomerular filtration rat ( eGFR ) , urea , cystatin C ; fast glucose ; bilirubin ; total cholesterol , high-density lipoprotein ( HDL ) , low-density lipoprotein ( LDL ) , triglyceride , N-terminal prohormone brain natriuretic peptide ( NT-proBNP ) ; hs-TnT ( high sensitive troponin T ) , iron ; ferritin ; unsaturated iron binding capacity ( UIBC ) , total iron binding capacity ( TIBC ) , transferrin saturation , soluble transferrin receptor ; pH , carbon dioxide partial pressure ( pCO2 ) , oxygen partial pressure ( pO2 ) , arterial oxygen saturation ( SaO2 ) , bicarbonate content ( HCO3- ) , base excess ( BE ) , lactate ; thyroid-stimulating hormone ( TSH ) , testosterone , dehydroepiandrosterone sulfate ( DHEAS ) , estradiol Electrocardiogram Echocardiography Chest X-ray Holter-ekg monitoring ambulatory blood pressure monitor impedance cardiography ( include assessment : resting heart rate ( HR ) , systolic diastolic blood pressure ( SBP DBP ) , thoracic fluid content ( TFC ) , cardiac index ( CI ) , stroke index ( SI ) , systemic vascular resistance index ( SVRI ) bioimpedance ( include assessment total body water ( TBW ) , intracellular extracellular water ( ICW , ECW ) ) applanation tonometry ( include assessment augmentation index ( AI ) central pulse pressure ( CPP ) )</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>patient either sex urgent hospitalization cause deterioration HF . unstable coronary artery disease include myocardial infarct within last 40 day prior recruitment stroke within 40 day prior recruitment cardiac surgery within 90 day prior recruitment pulmonary embolism severe pulmonary disease ( chronic obstructive pulmonary disease stage C/D , uncontrolled asthma , pulmonary hypertension ) chronic kidney disease ( stage 5 require dialysis ) severe inflammatory disease severe mental physical disorder patient ' refusal participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>heart failure</keyword>
	<keyword>renal failure</keyword>
	<keyword>prognosis</keyword>
	<keyword>impedance cardiography</keyword>
</DOC>